Arbutus Biopharma GAAP EPS of -$0.12 beats by $0.01, revenue of $5.95M misses by $3.23M

Nov. 09, 2022 7:40 AM ETArbutus Biopharma Corporation (ABUS)By: Deepa Sarvaiya, SA News Editor
  • Arbutus Biopharma press release (NASDAQ:ABUS): Q3 GAAP EPS of -$0.12 beats by $0.01.
  • Revenue of $5.95M (+78.1% Y/Y) misses by $3.23M.
  • As of September 30, 2022, the Company had cash, cash equivalents and investments in marketable securities of $190.2 million, as compared to $191.0 million as of December 31, 2021.

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.